Biolife Solutions (BLFS) Operating Leases (2019 - 2026)

Biolife Solutions (BLFS) has 8 years of Operating Leases data on file, last reported at $12.4 million in Q1 2026.

• On a quarterly basis, Operating Leases fell 11.73% year-over-year to $12.4 million in Q1 2026; TTM through Mar 2026 was $12.4 million, a 11.73% decrease from a year earlier, with the FY2025 full-year figure at $10.7 million, down 15.72% from the prior year.
• Operating Leases for Q1 2026 stood at $12.4 million, up from $10.7 million in the prior quarter.
• Over the last five years, Operating Leases for BLFS reached as high as $18.7 million in Q1 2022 and fell as low as $8.7 million in Q4 2023.
• Historically, Operating Leases has averaged $14.2 million across 5 years, with a median of $14.5 million in 2022.
• Across the five-year window, Operating Leases jumped 101.23% in 2022 and plunged 41.89% in 2023, its largest moves.
• Year by year, Operating Leases stood at $15.0 million in 2022, then slumped by 41.89% to $8.7 million in 2023, then soared by 45.43% to $12.6 million in 2024, then declined by 15.72% to $10.7 million in 2025, then advanced by 15.96% to $12.4 million in 2026.
• Per Business Quant data, the three most recent Operating Leases figures were $12.4 million in Q1 2026, $10.7 million in Q4 2025, and $13.2 million in Q3 2025.